Customer Education

Webinar: Emerging Biomarkers for the Diagnosis of Cardiac Pathologies

 

 What Does it Cover?

According to the World Health Organization (WHO) cardiovascular diseases (CVD’s) are the leading cause of death accounting for more than 17.3M deaths globally. Modern cardiac diagnostics tests and monitoring techniques are providing ever increasing insight into the health of the human heart. In this presentation we examine some of the new and emerging cardiac biomarkers that could complement existing diagnostic and prognostic methods and have the potential to revolutionize our current understanding of cardiac health.
 

 What Will You Learn?

  • Introduction to Cardiac Biomarkers
  • Trends in the Cardiac Diagnostic Market
  • New and emerging cardiac biomarkers
  • How these biomarkers may complement existing diagnostic tests

 Who Should Attend?

  • Diagnostic test developers and people with an interest in cvds

 

Speaker Bio
Rich Triglia
Product Manager, Immunoassay Kits and Technology
Rich holds a Master’s Degree in Immunology from a UC Berkely, San Francisco, and Stanford joint program. During his career he has spent time at Cetus, Pacific Biotech, and with us for the last 24 years. Prior to his current role managing out immunoassay kits and technologies he was involved in R&D work on extracellular matrix protein purification and light diagnostics for virus detection.